Research indicates that CBD may act against the growth of tumor cells

A new study released by the Newsweed portal, based on research published in the scientific journal Phytomedicine, indicates that cannabidiol (CBD) presents relevant antitumor potential in different types of cancer, based on the analysis of preclinical evidence available in the scientific literature.

The research, funded by the National Natural Science Foundation of China, reviewed experimental studies conducted in the laboratory and in animal models involving tumors such as glioblastoma, breast, lung, colorectal, prostate, and ovarian cancer.

The results indicate that CBD may interfere with multiple biological processes associated with tumor development and progression.

CBD and Cancer: acting on multiple cellular pathways

According to the authors, CBD has demonstrated the ability to inhibit the proliferation of cancer cells, reduce cell migration, and limit the formation of metastases in various experimental models. The compound's action occurs through the modulation of different cell signaling pathways related to tumor growth, inflammation, oxidative stress, and programmed cell death.

The study also indicates that CBD can interact with specific receptors, such as GPR55, associated with cancer progression, as well as influence mechanisms related to angiogenesis, the process of forming new blood vessels that promote tumor growth.

Read Also: 

Cannabis against cancer: meta-analysis reinforces therapeutic potential and calls for new studies

Association with conventional therapies

Another point highlighted by the research is the potential of CBD to increase the sensitivity of tumor cells to conventional oncological treatments, such as chemotherapy, in certain models analyzed. In some cases, the compound has shown to reduce tumor resistance to drugs already used in clinical practice.

According to the survey, controlled clinical trials in humans are still needed to confirm the efficacy, safety, dosage, and possible applications of CBD in oncological therapeutic protocols.

With information from NewsWeed.